Mohammad Zafar Imam

5PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational chemistryBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2026
An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

|May 12, 2023
In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes.

Mohammad Zafar Imam, Sussan Ghassabian, Andy Kuo

|Mar 01, 2023
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects.

Maree T Smith, Dehui Kong, Andy Kuo

|Jan 13, 2023
CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats.

Mohammad Zafar Imam, Andy Kuo, Sussan Ghassabian

|Jul 28, 2020
Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.

Mohammad Zafar Imam, Andy Kuo, Janet R Nicholson

Pageof 1

Frequent Collaborators

5 joint publications

Andy Kuo

5 joint publications

Maree T Smith

2 joint publications

Sussan Ghassabian

2 joint publications

Yunxin Cai